Research keywords (6)：
clinical research
, Regulatory science
, drug lag
, hematopoietic and lymphoid tumors
, chronic myeloid leukemia
, Ph-positive acute lymphoblastic leukemia
Research theme for competitive and other funds (3)：
2015 - 2018 Development of novel anti-leukemic therapy targeting clathrin-dependent endocytosis
2013 - 2016 Identification and characterization of CML stem cell during TKI treatment
2013 - 2016 Novel therapeutic approaches targeting intracellular trafficking of RTK mutants in acute myeloid leukemia cells.
Papers (44)：
Hirase Chikara, Matsumura Itaru, Kumode Takahiro, Serizawa Kentaro, Morita Yasuyoshi, Tanaka Hirokazu, Fukuoka Kazuya. Long-Term Clinical Outcomes of the Patients with Chronic Myeloid Leukemia Treated with Nilotinib as the 1st-Line Tyrosine Kinases Inhibitor at the Kindai university hospital. ACTA MEDICA KINKI UNIVERSITY. 2024. 49. 1. 15-25
Shota Tsukimoto, Atsuhiro Kitaura, Rina Yamamoto, Chikara Hirase, Shinichi Nakao, Yasufumi Nakajima, Takuro Sanuki. Comparative Analysis of the Hemodynamic Effects of Remimazolam and Propofol During General Anesthesia: A Retrospective Study. Cureus. 2024
Kenji Yamaji, Yoshitaka Iwanaga, Kazuyoshi Kakehi, Kosuke Fujita, Takayuki Kawamura, Chikara Hirase, Masafumi Ueno, Gaku Nakazawa. Prognostic Significance of Asymptomatic Cerebral Infarction in Patients After Cardiac Catheterization. International Heart Journal. 2024. 65. 1. 13-20
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
Kenji Yamaji, Yoshitaka Iwanaga, Takayuki Kawamura, Kosuke Fujita, Masakazu Yasuda, Toru Takase, Chikara Hirase, Masafumi Ueno, Gaku Nakazawa. Plaque characteristics and prognosis in patients with peripheral arterial disease by angioscopic analysis. Journal of Cardiology. 2022. 80. 1. 94-100
波江野高大, 三宅義昭, 井上舞子, 藤本昂, 角谷宏明, 藤井晶, 源周治, 口分田貴裕, 芹澤憲太郎, 谷口康博, et al. Retrospective analysis of autologous stem cell transplantation for Diffuse large B-cell lymphoma. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
谷口康博, 平瀬主税, 芦田隆司, 波江野高大, 角谷宏明, 源周治, 綿谷陽作, 口分田貴裕, 芹澤憲太郎, 頼晋也, et al. Clinical usefulness of Letermovir for patients with stem cell transplantation. 日本造血細胞移植学会総会プログラム・抄録集. 2021. 43rd
Recent topics in the development of anticancer drugs. 近畿大学医学雑誌. 2021. 46. 1-2
谷口康博, 芦田隆司, 森田泰慶, 平瀬主税, 頼晋也, 中山聖子, 芹澤憲太郎, 口分田貴裕, 井上宏昭, 岩田吉男, et al. Outcomes of allo-SCT for patients in non-remission especially with chemoresistance. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
佐野圭吾, 中村美紀, 平瀬主税. Report about Review Scheme of Approved Drugs Related to HSCT in Japan. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
2019/05 - 現在 Pharmaceuticals and Medical Devices Agency expert advisor
Awards (1)：
2011 - 公益財団法人大阪対がん協会 がん研究助成奨励金
Association Membership(s) (5)：
The Japan Society of Transfusion Medicine and Cell Therapy
, Japanese Society of Medical Oncology
, Japanese Board of Cancer Therapy
, The Japanese Society of Hematology
, The Japanese Society of Internal Medicine
